IVI MIDDLE EAST FERTILITY CLINIC IN MUSCAT UNVEILS LIMITED SPECIAL OFFER TO CELEBRATE OMANI WOMEN’S DAY

In commemoration of Omani Women’s Day (Wednesday, October 17, 2018), IVI Middle East Fertility Clinic in Muscat has unveiled a special offer paying tribute to women and their important role in nation building.

Muscat, Oman, 29 October 2018: In commemoration of Omani Women’s Day (Wednesday, October 17, 2018), IVI Middle East Fertility Clinic in Muscat has unveiled a special offer paying tribute to women and their important role in nation building.

Beginning October 17th to October 31st, 2018, the special package enables couples seeking to become pregnant via In-Vitro Fertilization (IVF) to avail of a consultation and an Anti-Mullerian Hormone (AMH) test to assess ovarian reserve, at a reduced cost of OMR 40.

Dr. Francisco Ruiz, Medical Director, IVI Fertility, Muscat, said: “Launching this special package is our way of showing our appreciation to women in Oman for their vital contributions to our society. We salute women for their hard work, persistence and their resilience. The Sultanate is what it is today because of their relentless support to drive the country’s prosperity in the 21st century.”

“Additionally, this special package is part of our ongoing initiative to provide hope to all couples experiencing difficulty conceiving by making our services accessible and more affordable. It complements our campaign to raise awareness about various mechanisms and technologies available to couples who want to become pregnant. We invite married couples to visit our clinic today until the end of the month to take advantage of this limited special offer,” he added.

The AMH test is currently one of the most accurate tools in assessing a woman’s ovarian reserve, which plays a crucial role in fertility. AMH can be performed any day throughout the menstrual cycle.

The Medical expertise provided at IVI Fertility clinic is world class and our group is renowned for its research and applicability of the latest advances in Assisted Reproductive Technologies (ART). The group observes the highest standards of care to help patients achieve a pregnancy all over the world.

MORE ON THIS TOPIC